Catherine Fooks SOLOVAY

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,139,471
- Issue date Nov 12, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,2,4-oxadiazole derivatives as liver X receptor agonists
- Patent number 11,427,586
- Issue date Aug 30, 2022
- Novartis AG
- Kelly D. Boss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,254,653
- Issue date Feb 22, 2022
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,208,399
- Issue date Dec 28, 2021
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds...
- Patent number 9,505,755
- Issue date Nov 29, 2016
- Novartis AG
- Christopher Michael Adams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds...
- Patent number 8,846,656
- Issue date Sep 30, 2014
- Novartis AG
- Christopher Michael Adams
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
- Publication number 20220340573
- Publication date Oct 27, 2022
- Novartis AG
- Kelly D. BOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE...
- Publication number 20220306617
- Publication date Sep 29, 2022
- Novartis AG
- Claire ADCOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20220251067
- Publication date Aug 11, 2022
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
- Publication number 20220064164
- Publication date Mar 3, 2022
- Novartis AG
- Kelly D. BOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361899
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361898
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS...
- Publication number 20140349995
- Publication date Nov 27, 2014
- Novartis AG
- Christopher Michael ADAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS...
- Publication number 20130184253
- Publication date Jul 18, 2013
- Novartis AG
- Christopher Michael ADAMS
- C07 - ORGANIC CHEMISTRY

Catherine Fooks SOLOVAY

Person

Patents Grantslast 30 patents

NLRP3 inflammasome inhibitors

1,2,4-oxadiazole derivatives as liver X receptor agonists

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds...

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds...

Patents Applicationslast 30 patents

1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS

SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE...

NLRP3 INFLAMMASOME INHIBITORS

1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS...

TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS...